D360 – Certara

Certara > D360

Certara Launches Version 10 of D360, Its Industry-leading Drug Discovery Informatics Platform

PRINCETON, NJ – Feb. 14, 2018 – Certara today announced the launch of version 10 of D360, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution used to query diverse cheminformatics and bioinformatics data sources to make informed go/no go research decisions.

0 comments. Click here to read/write comments.

Topics:

D360 Partner

D360 Partner is an affordable add-on product for D360 for external partners that allows for seamless, secure sharing of data and analysis while advancing communication and collaboration.

0 comments. Click here to read/write comments.

Topics:

Agile Research Informatics for Nimble Organizations: From Experiment to Decision

May 9, 2018 – David Lowis will describe a case study where D360 was used to replace older technologies at a biotechnology company. He will also show D360’s new visualization tools and share the future roadmap as D360 advances its support of biologics in addition to small molecules.

0 comments. Click here to read/write comments.

Topics:

D360 Express Scientific Data Informatics Hub

D360 Express is an out-of-the-box integrated solution specifically designed for discovery scientists at smaller pharmaceutical research organizations. It provides access, integration, analysis and visualization of scientific data from multiple data sources. D360 Express gets you up and running quickly and affordably.

0 comments. Click here to read/write comments.

Topics:

D360 Express

Scientific Data Informatics Hub for Discovery Research Small molecule drug discovery research requires the ability to access and understand biological, chemical, logistical, and computational data from a wide variety of sources. A major challenge for scientists is the significant time and resources needed to find and access this data quickly and efficiently in order to make […]

0 comments. Click here to read/write comments.

Topics:

D360 Pre-clinical

D360 removes the major roadblocks that preclinical scientists encounter when answering questions related to safety data by making the data easily available, in a format that is readily accessible and usable. As a result, answers are arrived at quickly and easily, and scientists are enabled to ask questions that were previously impossible to ask.

0 comments. Click here to read/write comments.

Topics:

D360 Discovery

D360 brings together data from different sources and provides integrated analysis and collaboration tools to support a wide variety of workflows across scientific disciplines.

0 comments. Click here to read/write comments.

Topics:

D360: Self-Service Data Access, SAR Analysis, and Molecular Design

Discovery drug research requires understanding complex biological, chemical, logistical and computational data from a wide variety of data sources. Certara’s D360 platform was specifically designed to meet the discovery researcher’s workflow needs.

0 comments. Click here to read/write comments.

Topics:

Certara Introduces the D360 Express Data Platform for Pharmaceutical R&D

PRINCETON, NJ – June 23, 2016 – The D360 packaged informatics solution reduces research cycle time, delivering faster insights for busy discovery scientists.

0 comments. Click here to read/write comments.

Topics:

D360 IT Maintenance Overhead

Providing scientists with access to project data and tools to analyze and collaborate is vitally important to improving the effectiveness of rational, data-driven research. This capability must be provided without undue burden or cost on already stretched IT resources. D360™ is a scientific informatics tool that meets these criteria.

0 comments. Click here to read/write comments.

Topics:

Cross-Study Search and Analysis of Pre-clinical Safety Data

Certara’s D360 enables scientists to focus on uncovering trends in their data, without the pain of figuring out how to access it. A global top 10 pharmaceutical company, devoted to discovering new medicines and new technologies for managing personal health, engaged in an initiative to better address cross-study analysis of pre-clinical safety data. Toxicologists, pathologists, […]

0 comments. Click here to read/write comments.

Topics:

Streamlined, Self-Service Access to Scientific Data

D360 enables scientists to easily access, analyze, and visualize chemical and biological data, enhance scientific capabilities. A small biotechnology company dedicated to the research and development of small molecule therapeutics engaged in an initiative to better address access and analysis of chemical and biological data by its scientists. Scientists at this company use IDBS’ ActivityBase®, […]

0 comments. Click here to read/write comments.

Topics:

Optimized Pre-clinical Informatics for Faster, Surer Development Decisions

A top 40 pharmaceutical company enhanced data access and decision support for pre-clinical safety with Certara’s D360 data access and analysis application and a specialized CDISC SEND-based database. Pre-clinical scientists at a top 40 pharmaceutical company faced delays of a day or more for data collation and transformation with each incremental data update received from […]

0 comments. Click here to read/write comments.

Topics:

Replacing In-House Informatics for Cost Savings and Enhanced Knowledge Access

Discovery team lowers IT costs and improves end-user functionality by standardizing on Certara’s D360 Drug Discovery Platform A multi-national pharmaceutical company had developed a custom informatics system, providing all scientists in its discovery organization with access to essential research data. While information access was well-served by the tool, over time, a long list of new […]

0 comments. Click here to read/write comments.

Topics:

Analyses Requiring Hours In The Past Reduced To Minutes

Medivir sees a fast return on its investment — time savings and enhanced informativeness of data activities The discovery arm of Medivir®, a mid-size, Swedish pharmaceutical company, sought an updated informatics infrastructure to improve the efficiency and flexibility of its data analysis and reporting. The group’s existing in-house tools could only create reports in a […]

0 comments. Click here to read/write comments.

Topics:

D360

Data Informatics Platform for Discovery Scientists Small molecule drug discovery research requires understanding complex biological, logistical, and computational data from a wide variety of data sources. A key challenge for discovery scientists is the ability to efficiently access the most current and relevant data from internal and external data sources, ideally in a consolidated and cohesive […]

0 comments. Click here to read/write comments.

Topics:

Scientific Informatics

Certara’s Informatics Platform Facilitates Scientific Data Access, Analysis and Collaboration within an Organization and Amongst Development Partners D360 Data Informatics Platform for Discovery Scientists D360™ is the industry-leading scientific data informatics hub used globally by over 5,000 discovery research scientists. It was designed to meet the discovery researcher’s workflow needs by providing a self-service data […]

0 comments. Click here to read/write comments.

Topics:

Software

Read More

0 comments. Click here to read/write comments.

Topics:

Speeding the Iterative Drug Design process

In this paper, we explore the issues in the effective use of modern pharmaceutical data mining applications. We discuss the development and capabilities that were built into the Discovery 360° application to address these issues, as part of Wyeth Pharmaceuticals Next Generation IT project (NextGen). Wyeth found that simplifying data access and integration of data […]

0 comments. Click here to read/write comments.

Topics:

The Highlights in Model-based Drug Development for 2014

Posted by Suzanne Minton

on Dec 30, 2014 6:13:30 PM

As the end of the year draws near, I want to thank all of our customers for letting us be your biosimulation and model based drug development solution provider. We feel honored to be able to play a small, but crucial role in your success in bringing safe and effective drugs to patients. 2014 has […]

0 comments. Click here to read/write comments.

Topics: PK/PD Modeling & Simulation, Scientific Informatics

1 2

MENU

Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog